Q4 2023 Holdings
Filed 2024-02-14 | 72 holdings | $2.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Guardant Health Inc | NOTE 11/1 | 40131MAB5 | $189.1M | $268,252,000 | 6.9% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $138.4M | $114,338,000 | 5.1% |
| Ascendis Pharma A/S | NOTE 2.250% 4/0 | 04351PAD3 | $130.4M | $126,897,000 | 4.8% |
| Exact Sciences Corp | NOTE 0.375% 3/0 | 30063PAC9 | $123.1M | $131,000,000 | 4.5% |
| Novocure LTD | NOTE 11/0 | 67011XAB9 | $117.9M | $135,834,000 | 4.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $94.2M | 715,209 | 3.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $81.0M | 1,289,965 | 3.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $75.9M | 1,647,311 | 2.8% |
| Nuvasive Inc | NOTE 0.375% 3/1 | 670704AJ4 | $74.3M | $80,530,000 | 2.7% |
| Insulet Corp | NOTE 0.375% 9/0 | 45784PAK7 | $72.7M | $63,000,000 | 2.7% |
| Tandem Diabetes Care Inc | NOTE 1.500% 5/0 | 875372AB0 | $67.2M | $71,051,000 | 2.5% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $61.5M | 4,215,573 | 2.3% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $60.8M | 568,157 | 2.2% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $58.3M | 153,204 | 2.1% |
| Bridgebio Pharma Inc | NOTE 2.250% 2/0 | 10806XAD4 | $57.3M | $67,294,000 | 2.1% |
| Insmed Inc | NOTE 1.750% 1/1 | 457669AA7 | $56.1M | $52,388,000 | 2.1% |
| Penumbra Inc(PEN) | COM | 70975L107 | $56.0M | 222,792 | 2.1% |
| Sarepta Therapeutics Inc | NOTE 1.250% 9/1 | 803607AD2 | $51.5M | $50,666,000 | 1.9% |
| Neogenomics Inc | NOTE 0.250% 1/1 | 64049MAB6 | $50.2M | $65,601,000 | 1.8% |
| Travere Therapeutics Inc | NOTE 2.500% 9/1 | 761299AB2 | $47.7M | $56,031,000 | 1.8% |
| Dexcom Inc | NOTE 0.250%11/1 | 252131AK3 | $47.2M | $45,000,000 | 1.7% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $44.5M | 1,118,961 | 1.6% |
| Paragon 28 Inc(FNAUSD) | COM | 69913P105 | $41.8M | 3,361,824 | 1.5% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $41.8M | 611,365 | 1.5% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $40.2M | 75,749 | 1.5% |
| Align Technology Inc(ALGN) | COM | 016255101 | $40.1M | 146,313 | 1.5% |
| Ironwood Pharmaceuticals Inc | NOTE 0.750% 6/1 | 46333XAF5 | $39.5M | $37,509,000 | 1.4% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $38.2M | 1,776,368 | 1.4% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $37.6M | 184,658 | 1.4% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $36.0M | 1,107,770 | 1.3% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $34.3M | 5,718,477 | 1.3% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $33.9M | 562,600 | 1.2% |
| Maravai Lifesciences Hldgs I(MRVI) | COM CL A | 56600D107 | $33.0M | 5,040,635 | 1.2% |
| Karyopharm Therapeutics Inc | NOTE 3.000%10/1 | 48576UAA4 | $33.0M | $65,976,000 | 1.2% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $30.7M | 495,100 | 1.1% |
| Alphatec Hldgs Inc | NOTE 0.750% 8/0 | 02081GAB8 | $28.4M | $26,750,000 | 1.0% |
| Alector Inc(ALEC) | COM | 014442107 | $26.5M | 3,324,308 | 1.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $24.3M | 196,200 | 0.9% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $23.7M | 906,820 | 0.9% |
| Guardant Health Inc(GH) | COM | 40131M109 | $20.5M | 758,928 | 0.8% |
| Glaukos Corp(GKOS) | COM | 377322102 | $19.3M | 242,760 | 0.7% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $19.0M | 681,101 | 0.7% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $18.9M | 1,169,490 | 0.7% |
| Repligen Corp(RGEN) | COM | 759916109 | $18.5M | 102,698 | 0.7% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $17.4M | 2,023,900 | 0.6% |
| Ironwood Pharmaceuticals Inc | NOTE 1.500% 6/1 | 46333XAH1 | $16.9M | $15,500,000 | 0.6% |
| Harrow Inc(HROW) | COM | 415858109 | $16.8M | 1,498,584 | 0.6% |
| Amgen Inc(AMGN) | COM | 031162100 | $16.8M | 58,200 | 0.6% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $15.0M | 2,318,050 | 0.6% |
| Invitae Corp | NOTE 2.000% 9/0 | 46185LAB9 | $14.9M | $16,781,000 | 0.5% |